You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced Renal Cell Carcinoma

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AADC/TDC in Advanced Parkinson's Disease

Not yet recruiting
  • Parkinson Disease
    • (no location specified)
    Dec 9, 2022

    Using Peripheral Blood Circulating Tumor DNA in Cervical Cancer

    Recruiting
    • Locally Advanced Cervical Cancer
    • detect HPV and genetic variants
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Oct 28, 2022

    Covid-19 Vaccine on Allogeneic Hematopoietic Stem Cell

    Recruiting
    • Hematologic Diseases
    • COVID-19 vaccine(donor)
    • COVID-19 vaccine(patient)
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Nov 8, 2022

    Prostate Cancer Trial in Guangzhou (Goserelin Acetate Sustained-Release Microspheres for Injection, Zoladex 10.8 MG Drug

    Not yet recruiting
    • Prostate Cancer
    • Goserelin Acetate Sustained-Release Microspheres for Injection
    • Zoladex 10.8 MG Drug Implant
    • Guangzhou, China
      Sun Yat-sen Memorial Hospital of Sun Yat-sen University
    May 3, 2023

    Chronic Kidney Disease Trial in Dalian (optimal start time, late start time)

    Active, not recruiting
    • Chronic Kidney Disease
    • optimal start time
    • late start time
    • Dalian, Liaoning, China
      the First Affiliated Hospital of Dalian Medical University
    Apr 15, 2022

    Recurrent Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 Trial in Houston

    Active, not recruiting
    • Recurrent Lung Non-Small Cell Carcinoma
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 31, 2022

    A Nationwide Multicenter, Ambispective Real-world Study of

    Recruiting
    • Breast Cancer
      • Zhengzhou, Henan, China
        Henan cancer hospital
      Sep 15, 2022

      Type2 Diabetes Trial in Amsterdam (EMPA/LINA 10/5 mg QD (n=22), LINA/EMPA 5/10 mg QD (N=22), Gliclazide 30 mg QD/BID (N=22))

      Active, not recruiting
      • Type2 Diabetes
      • EMPA/LINA 10/5 mg QD (n=22)
      • +2 more
      • Amsterdam, Noord-Holland, Netherlands
        VU University Medical Center
      Jan 13, 2022

      NSCLC Trial in Durham (Nivolumab, Ipilimumab, Paclitaxel)

      Active, not recruiting
      • Non-small Cell Lung Cancer
      • Durham, North Carolina
        Duke University Medical Center
      Apr 22, 2022

      Sickle Cell Disease Without Crisis Trial in Chapel Hill (G6PD Deficient Red Blood Cell Transfusion, Non-G6PD deficient Red Blood

      Recruiting
      • Sickle Cell Disease Without Crisis
      • G6PD Deficient Red Blood Cell Transfusion
      • Non-G6PD deficient Red Blood Cell Transfusion
      • Chapel Hill, North Carolina
        University of North Carolina at Chapel Hill
      Aug 15, 2022

      Limited Stage Small Cell Lung Cancer, Not Progressed After First-line Chemoradiotherapy Trial in Jinan (TQB2450 Injection +

      Recruiting
      • Limited Stage Small Cell Lung Cancer
      • Not Progressed After First-line Chemoradiotherapy
      • TQB2450 Injection + Anlotinib Hydrochloride Capsules
      • Jinan, Shandong, China
        Cancer Hospital Affiliated to Shandong First Medical University
      Jul 5, 2023

      Epstein-Barr Virus Infections, Post-Transplant Lymphoproliferative Disorder, Lymphoma Trial in Montreal (Group A, Group B)

      Recruiting
      • Epstein-Barr Virus Infections
      • +2 more
      • Group A
      • Group B
      • Montreal, Quebec, Canada
        Hôpital Maisonneuve-Rosemont
      Apr 5, 2022

      Effect of Drug Trial in Taichung (Nivolumab, all trans retinoic acid)

      Completed
      • Effect of Drug
      • Taichung, Please Select, Taiwan
        China Medical University Hospital
      Jul 28, 2022

      Biliary Tract Cancer Trial (GEN-001, Pembrolizumab, mFOLFOX)

      Not yet recruiting
      • Biliary Tract Cancer
      • (no location specified)
      Aug 16, 2023

      Long-Term Sequelae of SARS-COV-2 Infection: Diabetes Mellitus

      Not yet recruiting
      • COVID-19
      • Diabete Mellitus
      • Measure of physiologic parameters
      • San Antonio, Texas
        Texas Diabetes Institute - University Health System
      May 17, 2023

      Advanced or Metastatic Solid Tumors, Ovarian Cancer, Gastric Cancer Trial in United States (NC410)

      Recruiting
      • Advanced or Metastatic Solid Tumors
      • +3 more
      • Bethesda, Maryland
      • +4 more
      May 25, 2022

      CT Perfusion Parameters for Advanced HCC Treated by Systemic

      Completed
      • Advanced HCC Treated by Systemic Immunotherapy
        • Nancy, France
          CHRU Nancy
        Oct 13, 2022

        Lymphoma, HIV Trial in United States (Autologous transplant, BCNU, Etoposide)

        Completed
        Has Results
        • Lymphoma
        • HIV
        • Autologous transplant
        • +4 more
        • Duarte, California
        • +15 more
        Dec 6, 2022

        HER2-negative Breast Cancer Trial in Budapest (device, drug, procedure)

        Recruiting
        • HER2-negative Breast Cancer
        • Oncotherm EHY-2030
        • +4 more
        • Budapest, Hungary
          Division of Oncology, Department of Internal Medicine and Oncolo
        May 25, 2023

        Advanced Cancer Trial in Aurora, New York (Psilocybin 25 mgs, Psilocybin 1 mg, Psychotherapy)

        Not yet recruiting
        • Advanced Cancer
        • Psilocybin 25 mgs
        • +2 more
        • Aurora, Colorado
        • +1 more
        May 26, 2022

        Pancreatic Cancer Trial (Chemotherapy, Radiation)

        Active, not recruiting
        • Pancreatic Cancer
        • (no location specified)
        May 30, 2022

        Metabolic Syndrome on Antiviral Response in People With Chronic

        Not yet recruiting
        • Chronic Hepatitis b
          • (no location specified)
          Jan 21, 2023

          Aggressive Non-Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma, Recurrent DLBCL Trial in Rochester (procedure, biological,

          Active, not recruiting
          • Aggressive Non-Hodgkin Lymphoma
          • +9 more
          • Cryosurgery
          • +5 more
          • Rochester, Minnesota
            Mayo Clinic in Rochester
          Aug 9, 2022

          Carcinoma, Hepatocellular Trial in Loma Linda (Proton Beam Radiotherapy, Sorafenib)

          Terminated
          Has Results
          • Carcinoma, Hepatocellular
          • Loma Linda, California
            Loma Linda University Medical Center
          Sep 21, 2021

          Very Advanced Maternal Aged Pregnants and Early Adolescent

          Completed
          • Advanced Maternal Age Pregnancy
          • Early Pregnancy
            • (no location specified)
            Jul 30, 2022